Диссертация (1139978), страница 31
Текст из файла (страница 31)
… д.м.н./ Нодель Марина Романовна. – М., – 2015.16.Преображенская И.С. Деменция с тельцами Леви: дисс. ... докт мед наук/Преображенская Ирина Сергеевна. – М. – 2005.17.Пономарев В.В. Лабораторные биомаркеры ранней диагностики болезниПаркинсона / В.В. Пономарев, А.В. Бойко, О.А. Ионова //International neurological journal. – 2016. – №3 (81). – с. 54-58.18.Пчелина С.Н. Альфа-синуклеин как биомаркер болезни Паркинсона/ С.Н.Пчелина // Анналы неврологии. – 2011. – Том 5 №4. – с.46-5119.Селиверстов А.Ю. Современные тенденции в изучении двигательных расстройств. Обзор 69-го конгресса Американской академии неврологии (Бостон, 22-28 апреля 2017) / Селиверстов А.Ю. // Бюллетень Национальногообщества по изучению болезни Паркинсона и расстройств движения.
– 2017– №2 – с. 6-13.20.Стёпкина Д.А. Ривастигмин (экселон) в лечении болезни Паркинсона с деменцией / Д.А. Стёпкина, В.В.Захаров // Русский медицинский журнал. –2007. – Т.15.– №.22. – С.1614-1618.21.Тишкова И. Г. Деменция с тельцами Леви и вегетативная регуляция сердечной деятельности / И.Г. Тишкова , И.С.Преображенская // Клиническаяневрология – 2010 – Том4 №2 – с. 15-23.17922.Труфанов А.Г. Возможности МРТ в диагностике и оценке прогрессированияБП /А.Г. Труфанов, И.В.Литвиненко // Болезнь Паркинсона и расстройствадвижений Руководство для врачей по материалам III национального конгресса по болезни Паркинсона и расстройствам движения. – М.
– 2014– c.12623.Шток В.Н. Экстрапирамидные расстройства / В.Н. Шток, И.А. ИвановаСмоленская, О.С. Левин с соавт. – М.: МЕДпресс-информ, – с.2002–606.24.Яхно Н.Н. Деменции: руководство для врачей / Н.Н.Яхно, А.Б.Локшина,Н.Н. Кобернская с соавт. – 3-е изд. – М.: МЕДпреcс-информ, – 2011. – с.272.25.Aarsland D. Cognitive impairment in Parkinson's disease and dementia withLewy bodies / D. Aarsland // Parkinsonism & Related Disorders [ParkinsonismRelat Disord] – 2016 – Jan.
- Vol. 22 Suppl 1. – р. 144-8.26.Aarsland D.The epidemiology of dementia associated with Parkinson disease /D.Aarsland // J Neurol Sci – 2010.– 289.– р.18-22.27.Aarsland D. Risk of dementia in Parkinson's disease: a community-based, prospective study /Aarsland D., Andersen K., Larsen J.P.
et al. // Neurology – 2001.– 56. – р.730-736.28.Aarsland D.Prevalence and characteristics of dementia in Parkinson disease: an 8year prospective study / Aarsland D., Andersen K., Larsen J.P., Lolk A., KraghSorensen P. //Arch Neurol – 2003. – 60 – р.387–392.29.Aarsland D.Сomparative study of psychiatric symptoms in dementia with Lewybodies and Parkinson's disease with and without dementia / Aarsland D., BallardC., Larsen J.P., McKeith I. A.//Int J Geriatr Psychiatry –2001.
–16.– р. 528–536.30.Aarsland D. Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia / Aarsland D., Ballard С. A., Broadstock M. // Curr Neurol Neurosci Rep.– 2012.–Vol.12.– р.492–50.31.Aarsland D. Neuropsyhyatric symptom in patients with Parkinson’s disease anddementia: frequency, profile and associated care giver stress / Aarsland D., Bronnick K.// J.Neurol Neuroserg Psychiat – 2007. – р.36-42.18032.Aarsland D. Performance on the dementia rating scale in Parkinson's disease withdementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease / Aarsland D., Litvan I., Salmon D., GalaskoD., Wentzel-Larsen T, Larsen J.P.
// J Neurol Neurosurg Psychiatry –2003. –Vol.74.–р.1215–1220.33.Aarsland D. Role of cholinesterase inhibitors in Parkinson’s disease and dementiawith Lewy bodies / Aarsland D., Mosimann U.P., McKeith I.G. //J Geriatr Psychiatry Neurol –2004.
–Vol.17. – р.164-17.34.Alexopoulos G.S. Cornell scale fordepression in dementia / AlexopoulosG.S.,Abrams R.C., Yang R.C., Shamoian C.A. // Biol.Psych. –1988. – 36(3). – р.271-284 p.35.Alves G.Cigarette smoking in Parkinson’s disease: influence on disease progression / Alves G., Kurz M., Lie S.A., Larsen J.P.// Mov Disord. – 2004. –Vol.19 –р.1087–1092.36.Alves G.Changes in motor subtype and risk for incident dementia in Parkinson’sdisease / Alves G., Larsen J.P., Emre M.,Wentzel-Larsen T., Aarsland D. // MovDisord– 2006. – Vol.21 – р.1123–1130.37.Au W.L. Levodopa and the feedback process onset-shifting in Parkinson’s disease / Au W.L., Zhou J., Palmes P., Sitoh Y-Y., Tan L.C., Rajapakse J.C.// HumBrain Mapp, – 2012. – Vol.
33. – р. 27-39.38.Avrom L.Dementia in Parkinson’s Disease / Avrom L.,Kurtz M.D.,Daniel I.//Current Treatment Options in Neurology. – 2011. – Vol. 13 – Issue 3–р. 242-254.39.Ballard C.G. Fluctuations in attention: PD dementia vs DLB with parkinsonism /Ballard C.G., Aarsland D., McKeith I., et al. // Neurology – 2002. – Vol.59. – р.1714–1720.40.Beatty W.W.Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS / Beatty W.W., Ryder K.A., Gontkovsky S.T., Scott J.G.,McSwan K.L., Bharucha KJ. //Arch Clin Neuropsychol – 2003.
– Vol.18. –р.509–520.18141.Benoit M. One-year longitudinal evaluation of neuropsychiatric symptoms inAlzheimer's disease. The REAL.FR Study / /Benoit M., Robert P.H., Staccini P etal. / J Nutr Health Aging – 2005. – Vol.9. – р.95–99.42.Bentley P. Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging / Bentley P., Driver J., Dolan R.J. //Prog Neurobiol . – 2011. - Vol. 94. – р. 360-88.43.Benton A.L. Visuospatial judgement. A clinical test / Benton A.L., Varney N.R.,Hamsher K.
//Arch.Neurol. – 1978. – Vol.35. – р. 364-367.44.Berlyand Y. An Alzheimer's Disease-Derived Biomarker Signature IdentifiesParkinson's Disease Patients with Dementia / Berlyand Y. , Weintraub D., XieS.X. // Plos One [PLoS One] –2016 – Jan 26 – Vol. 11 (1). – р.e 0147319.45.Biundo R. Cognitive profiling of Parkinson disease patients with mild cognitiveimpairment and dementia / Biundo R., Weis L., Facchini S., Formento-Dojot P.,Vallelunga A., Pilleri M, et al. // Parkinsonism Relat. Disord , – 2014, – Vol.
20.– р. 394-9.46.Boeve B.F.REM sleep behavior disorder in Parkinson’s disease and dementiawith Lewy bodies / Boeve B.F., Silber M.H., Ferman T.J. // J. Geriatr PsychiatryNeurol – 2004. – Vol.17 – р.146-157.47.Bonanni L.EEG comparisons in early Alzheimer’s disease, dementia with Lewybodies and Parkinson's disease with dementia patients with a 2-year follow-up /Bonanni L., Thomas A., Tiraboschi P., Perfetti B., Varanese S., Onofrj M .//Brain – 2008, –– Vol. 131. – р.690-705.48.Boronni B. Structural and functional imaging study in Dementia with Lewy Bodies and Parkinson’s Disease Dementia / Boronni B., Premi E. Barbara FormentiА. // Parkinsonism & Related Disorders.
– 2015. – p.78-85.49.Bosboom J.L.W. Resting state oscillatory brain dynamics in Parkinson’s disease:an MEG study/ Bosboom J.L.W., Stoffers D., Stam C.J., van Dijk B.W., VerbuntJ., Berendse HW, et al. // Clin. Neurophysiol – 2006.–Vol. 117.– p. 2521-31.18250.Braak H. Staging of brain pathology related to sporadic Parkinson's disease /Braak H., Del Tredici K., Rüb U., de Vos R.A.I., Jansen Steur E.N.H, Braak //Neurobiol Aging.–2003–Vol.24–р.197–210.51.Bronnick K.
Neuropsychiatric disturbances in Parkinson's disease clusters in fivegroups with different prevalence of dementia / Bronnick K., Aarsland D., LarsenJ.P. //Acta Psychiatr Scand. – 2005. – Vol.112.–р.201–207.52.Bronnick K. Profile of cognitive impairment in dementia associated with Parkinson’s disease compared with Alzheimer’s disease / Bronnick K.,Emre M.,LanneR. et all // J. Neurol Neurosurg Psychiat. – 2007.–p.1064-106853.Brück A. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson’s disease is related to dopaminergic hypofunction in the caudate nucleus / Brück A., Portin R., Lindell A., Laihinen A., Bergman J., Haaparanta M., et al. .// Neurosci Lett.–2001.–Vol.
311–p. 81-4.54.Burn D.J.Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’sdisease withdementia, and dementia with Lewy bodies / Burn D.J., Rowan E.N.,Allan L.M., et al. // J Neurol Neurosurg Psychiatry. – 2006. – Vol.77. –р.585–589.55.Buschman T.J. Top-down versus bottom-up control of attention in the prefrontaland posterior parietal cortices / Buschman T.J., Miller E.K. // Science.–2007.–vol.
315 – p. 1860-2.56.Buter T.C. Dementia and survival in Parkinson disease: a 12-year populationstudy / Buter T.C., van den Hout A., Matthews F.E., Larsen J.P., Brayne C.,Aarsland D.// Neurology–2008. – Vol.70.–р.1017–1022.57.Cahn-Weiner D.A. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease / Cahn-Weiner D.A., Grace J., Ott BR, Fernandez H.H., Friedman J.H.
//Neuropsychiatry Neuropsychol Behav Neuro.–2002.–Vol.15–р.79–81.58.Choi S.H. Volumetric analysis of the substantia innominata in patients with Parkinson’s disease according to cognitive status / Choi S.H., Jung T.M., Lee J.E.,Lee S-K., Sohn Y.H., Lee P.H.// NeurobiolAging.–2012.–Vol. 33.–p. 1265-7218359.Christopher L. Combined insular and striatal dopamine dysfunction are associatedwith executive deficits in Parkinson’s disease with mild cognitive impairment /Christopher L., Marras C., Du - Canning S., Koshimori Y., Chen R., Boileau I, etal. //Brain . – 2014.–Vol.137–p. 565-75.60.Compta Y. Lewyand Alzheimer-type pathologies in Parkinson’sdisease dementia:which is more important?/ Compta Y., Parkkinen L., O’Sullivan S.S. //Oxford J.Med.
Brain – 2011.– 134(5) – р.493 – 1505.61.Costa A. Free and cued recall memory in Parkinson’s disease associated withamnestic mild cognitive impairment / Costa A., Monaco M., Zabberoni S., PeppeA., Perri R., Fadda L., et al. // PLoSOne – 2014 – Vol. 9. – p. e86233.62.Cummings J.L. Alzheimer's disease and Parkinson's disease: comparison ofspeech and language alterations. / Cummings J.L., Darkins A., Mendez M., HillM.A., Benson D.F.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
